<DOC>
	<DOCNO>NCT01285817</DOCNO>
	<brief_summary>To establish anti-tumour effect metronomic combination regimen define progression-free survival ( PFS ) two cycle treatment ( 4 month ) 12 month treatment , well response rate number cycle treatment ( `` best response '' ) . To define safety profile combination . To characterize pharmacodynamics drug combination use angiogenic marker ( CEP , CEC , microparticles ) .</brief_summary>
	<brief_title>A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib Weekly Vinblastine Children Adolescents With Relapsed Progressing soliD Tumours .</brief_title>
	<detailed_description>Multi-center , combination phase II study , open-label , non-comparative , non-randomized . All progressive recurrent solid tumour include Phase II study , provide curative option anymore . Total expected number patient ( minimum maximum ) : 54 90 ( 2-stage design )</detailed_description>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Vinblastine</mesh_term>
	<criteria>Patients must histologically cytologically confirm malignant solid tumour . Progression recurrence tumour radiologically establish confirm within 4 week prior inclusion . Disease must consider refractory line conventional therapy effective conventional treatment exists . Age : ≥4 21 year age study entry Life expectancy : least 8 week ECOG Performance status ≤ 1 LanskyPlay Scale ≥ 70 % Written inform consent parent/guardian patient assent Wash 4 week case prior chemotherapy , 6 week treatment include nitrosoureas , 2 week case vincristine alone ; 6 week case prior radiotherapy ( except palliative radiotherapy non measurable lesion ) . Patients must recover acute toxic effect prior therapy enrolment study Able comply schedule followup management toxicity All patient reproductive potential must practice effective method birth control study . Female patient age &gt; 12 year must negative pregnancy test within 7 day study treatment . Capable swallow oral medication Pregnant breast feed woman . Uncontrolled intercurrent illness active infection Inability swallow oral medication . Patients anticonvulsant allow study</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>